EU Regulators Warn of Counterfeit Copies of Cancer Drug Herceptin
EU regulators have issued a warning that several batches of the cancer medicine Herceptin (trastuzumab) have been “tampered with,” falsified and reintroduced into the supply chain, potentially putting patients at risk.
High-cost cancer medications like Herceptin have become an increasingly tempting target for thieves and counterfeiters in recent years. While they lack the ready market that some drugs like Viagra have, their extraordinary cost means extraordinary paydays. US officials warned of a similar scare in February 2012, when counterfeit copies of Roche’s Avastin (bevacizumab) were found to have infiltrated the US supply chain. Another batch of the counterfeit drug was found in April 2012.
In the wake of those findings, FDA went after more than a dozen physicians, who were blamed for purchasing the Avastin from unauthorized suppliers in the pursuit of higher profit margins.
Related Posts
Two nabbed with 6.5 kg contraband items in Manipur: Police
Chandel (Manipur) , March 18 (ANI): Two alleged smugglers were arrested and 6.5...
Woman jailed for smuggling 3m illicit cigarettes into UK
A London woman who smuggled three million illicit cigarettes into the UK using...
Haydn Morgan: Counterfeit products – a global threat
The number of counterfeit products being sold is continuously rising, recently...
Novel Research: Illegal cigarettes trade in Romania soars to 16.9pct in May
The cigarettes smuggling increased in May 2016 to a market share of 16. percent,...